Session(s)
- Greater Treatment Benefit with Omalizumab in Children with Increased Asthma Severity: Expl...
Sunday, May 20 9:15 AM - 11:15 AM - Characterization of Pediatric, Adolescent and Adult Asthma Patients by GINA Step and Blood...
Sunday, May 20 11:15 AM - 1:00 PM - Demographic, Clinical Characteristics and Control Status of Pediatric, Adolescent and Adul...
Sunday, May 20 11:15 AM - 1:00 PM - Epidemiology of Asthma by GINA Step in a US Commercially Insured Population [Board No. P10...
Sunday, May 20 11:15 AM - 1:00 PM - Genomic and Transcriptomic Analyses of CC16 as a Biomarker for Asthma [Board No. P1068]
Sunday, May 20 11:15 AM - 1:00 PM - A Randomized, Controlled Phase 3 Study, LIBERTY ASTHMA QUEST, Evaluating the Efficacy and ...
Sunday, May 20 2:15 PM - 4:15 PM - Upregulation of Paraxonase 1 (PON1) in Severe Asthma [Board No. 419]
Sunday, May 20 2:15 PM - 4:15 PM - Dupilumab Treatment Produces Rapid and Sustained Improvements in FEV1 in Patients with Unc...
Wednesday, May 23 9:30 AM - 9:45 AM - Chair
Wednesday, May 23 12:15 PM - 1:15 PM - Questions and Answers/Discussion with All Speakers
Wednesday, May 23 1:05 PM - 1:15 PM - Bronchial Alveolar Lavage Gene Expression Discovers New Biological Mechanisms and Further ...
Wednesday, May 23 1:30 PM - 1:45 PM - Identification of Inflammatory Gene Expression Patterns Associated with Viral Upper Respir...
Wednesday, May 23 2:30 PM - 2:45 PM